DiagnosTear Signs Letter of Intent to Advance Commercial Expansion of TeaRx(TM) in India #biotech #healthcare #lifesciences #medtech #stock #CSEStocks #SmallCaps #Investing
Vancouver, British Columbia--(Newsfile Corp. - January 22, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company"), an innovator in point-of-care ocular diagnostics, today announced the signing of a Letter of Intent (LOI) with Renovate Biologicals Pvt. Ltd. ("Renovate"), a Hyderabad-based distribution company active in the ophthalmic market, to support the commercial evaluation and potential distribution of TeaRx™ in India.The LOI is part of DiagnosTear's...
http://dlvr.it/TQW8q4
http://dlvr.it/TQW8q4
Comments
Post a Comment